Company intelligence / Profile preview

Anabaena

Cleveland, Ohio, United Statesusgs.gov ↗

Ownership: Private
Development stage: Other

Overview

Anabaena was an academic project focused on developing plant-based systems for producing RNA therapeutics using virus-like particles. The technology aimed at applications in cancer, vaccines, and tissue regeneration but has not reported any clinical results or programs beyond the conceptual/prototype phase as of 2022.

Therapeutic areas: OtherOncologyInfectious Diseases
Modalities: RNA therapyVirus-like particle-based delivery
Industry: Academic Hospital/University/Research

Beyond the preview

Go deeper on Anabaena.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anabaena.

Explore the full profile